A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivity. (2013)
Attributed to:
MRC Centre for Transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bcp.12042
PubMed Identifier: 23171128
Publication URI: http://europepmc.org/abstract/MED/23171128
Type: Journal Article/Review
Volume: 75
Parent Publication: British journal of clinical pharmacology
Issue: 6
ISSN: 0306-5251